株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

分子細胞遺伝子学市場:製品別、技術別、用途別、エンドユーザー別、地域別:世界市場規模、シェア、発展、成長、需要予測

Molecular Cytogenetics Market by Offering, by Technology, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014 - 2023

発行 Prescient & Strategic Intelligence Private Limited 商品コード 666131
出版日 ページ情報 英文 203 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.34円で換算しております。
Back to Top
分子細胞遺伝子学市場:製品別、技術別、用途別、エンドユーザー別、地域別:世界市場規模、シェア、発展、成長、需要予測 Molecular Cytogenetics Market by Offering, by Technology, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014 - 2023
出版日: 2018年06月01日 ページ情報: 英文 203 Pages
概要

当レポートでは、世界の分子細胞遺伝子学市場について調査し、市場の現状と製品別、技術別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査の背景

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場セグメントの定義
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
  • 市場動向
    • 動向
    • 促進因子
    • 阻害因子
  • ポーターズファイブフォース分析

第5章 市場規模と予測

  • 製品別
  • 製技術別
  • 製用途別
  • 製エンドユーザー別
  • 地域別

第6章 北米

第7章 欧州

第8章 アジア太平洋地域

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 世界の戦略的動向

  • 合併・買収
  • 製品上市・認可
  • 提携
  • その他

第12章 企業プロファイル

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 5 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 6 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 7 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 8 GLOBAL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 9 GLOBAL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 10 GLOBAL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 11 GLOBAL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 12 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 13 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 14 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 15 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 16 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY REGION, $M (2014-2017)
  • TABLE 17 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY REGION, $M (2018-2023)
  • TABLE 18 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 19 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 20 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 21 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 22 NORTH AMERICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 23 NORTH AMERICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 24 NORTH AMERICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 25 NORTH AMERICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 26 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 27 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 28 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 29 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 30 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2017)
  • TABLE 31 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 32 U.S. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 33 U.S. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 34 U.S. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 35 U.S. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 36 U.S. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 37 U.S. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 38 U.S. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 39 U.S. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 40 U.S. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 41 U.S. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 42 U.S. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 43 U.S. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 44 CANADA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 45 CANADA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 46 CANADA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 47 CANADA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 48 CANADA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 49 CANADA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 50 CANADA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 51 CANADA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 52 CANADA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 53 CANADA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 54 CANADA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 55 CANADA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 56 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 57 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 58 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 59 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 60 EUROPE CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 61 EUROPE CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 62 EUROPE KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 63 EUROPE KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 64 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 65 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 66 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 67 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 68 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2017)
  • TABLE 69 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 70 GERMANY MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 71 GERMANY MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 72 GERMANY MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 73 GERMANY MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 74 GERMANY CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 75 GERMANY CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 76 GERMANY KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 77 GERMANY KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 78 GERMANY MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 79 GERMANY MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 80 GERMANY MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 81 GERMANY MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 82 U.K. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 83 U.K. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 84 U.K. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 85 U.K. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 86 U.K. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 87 U.K. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 88 U.K. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 89 U.K. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 90 U.K. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 91 U.K. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 92 U.K. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 93 U.K. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 94 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 95 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 96 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 97 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 98 APAC CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 99 APAC CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 100 APAC KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 101 APAC KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 102 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 103 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 104 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 105 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 106 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2017)
  • TABLE 107 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 108 JAPAN MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 109 JAPAN MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 110 JAPAN MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 111 JAPAN MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 112 JAPAN CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 113 JAPAN CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 114 JAPAN KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 115 JAPAN KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 116 JAPAN MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 117 JAPAN MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 118 JAPAN MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 119 JAPAN MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 120 CHINA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 121 CHINA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 122 CHINA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 123 CHINA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 124 CHINA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 125 CHINA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 126 CHINA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 127 CHINA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 128 CHINA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 129 CHINA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 130 CHINA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 131 CHINA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 132 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 133 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 134 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 135 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 136 LATAM CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 137 LATAM CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 138 LATAM KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 139 LATAM KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 140 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 141 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 142 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 143 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 144 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2017)
  • TABLE 145 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 146 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 147 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 148 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 149 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 150 BRAZIL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 151 BRAZIL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 152 BRAZIL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 153 BRAZIL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 154 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 155 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 156 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 157 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 158 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 159 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 160 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 161 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 162 MEA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 163 MEA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 164 MEA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 165 MEA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 166 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 167 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 168 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 169 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 170 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2017)
  • TABLE 171 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 172 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2017)
  • TABLE 173 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018-2023)
  • TABLE 174 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2017)
  • TABLE 175 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018-2023)
  • TABLE 176 SOUTH AFRICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 177 SOUTH AFRICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 178 SOUTH AFRICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014-2017)
  • TABLE 179 SOUTH AFRICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018-2023)
  • TABLE 180 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2017)
  • TABLE 181 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018-2023)
  • TABLE 182 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2017)
  • TABLE 183 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018-2023)
  • TABLE 184 ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 185 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 186 DANAHER CORPORATION - AT A GLANCE
  • TABLE 187 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 188 BIO-RAD LABORATORIES - AT A GLANCE
  • TABLE 189 BIO-RAD LABORATORIES, INC. - KEY FINANCIAL SUMMARY
  • TABLE 190 F. HOFFMANN LA-ROCHE AG - AT A GLANCE
  • TABLE 191 F. HOFFMANN LA-ROCHE AG - KEY FINANCIAL SUMMARY
  • TABLE 192 AGILENT TECHNOLOGIES INC. - AT A GLANCE
  • TABLE 193 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 194 PERKINELMER INC. - AT A GLANCE
  • TABLE 195 PERKINELMER INC. - KEY FINANCIAL SUMMARY
  • TABLE 196 ILLUMINA INC. - AT A GLANCE
  • TABLE 197 ILLUMINA INC. - KEY FINANCIAL SUMMARY
  • TABLE 198 QUEST DIAGNOSTICS INC.- AT A GLANCE
  • TABLE 199 QUEST DIAGNOSTICS INC. - KEY FINANCIAL SUMMARY
  • TABLE 200 NEOGENOMICS INC.- AT A GLANCE
  • TABLE 201 NEOGENOMICS INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL MOLECULAR CYTOGENETICS SUMMARY
  • FIG 9 PORTER'S FIVE FORCES ANALYSIS
  • FIG 10 SNAPSHOT OF GLOBAL MOLECULAR CYTOGENETICS MARKET (2017)
  • FIG 11 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 12 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 13 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 14 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 15 WORLDWIDE MAJOR MARKETS FOR MOLECULAR CYTOGENETICS
  • FIG 16 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIG 17 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 18 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 19 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 20 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 21 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2023)
  • FIG 22 EUROPE MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIG 23 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 24 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 25 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 26 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 27 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2023)
  • FIG 28 APAC MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIG 29 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 30 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 31 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 32 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 33 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2023)
  • FIG 34 LATAM MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIG 35 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 36 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 37 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 38 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 39 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2023)
  • FIG 40 MEA MOLECULAR CYTOGENETICS MARKET SNAPSHOT
  • FIG 41 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014-2023)
  • FIG 42 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014-2023)
  • FIG 43 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014-2023)
  • FIG 44 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014-2023)
  • FIG 45 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014-2023)
  • FIG 46 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG 47 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG 48 BIO-RAD LABORATORIES REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)
  • FIG 49 F. HOFFMANN LA-ROCHE AG - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)
  • FIG 50 AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)
  • FIG 51 PERKINELMER INC. - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)
  • FIG 52 ILLUMINA INC. - REVENUE SPLIT BY GEOGRAPHY (2017)
  • FIG 53 QUEST DIAGNOSTICS INC. - REVENUE SPLIT BY SEGMENT (2017)
  • FIG 54 NEOGENOMICS INC. - REVENUE SPLIT BY SEGMENT (2017)
目次

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023,

The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities.

Insights on market segments

Based on offering, the molecular cytogenetics market has been categorized into consumables, software and services and instruments. Globally, the market for software and services is expected to register fastest growth, with CAGR of 10.5% during the forecast period. This can be attributed to rapid adoption of automation in laboratory process and rising preference for outsourcing of expensive services.

Based on technology, the molecular cytogenetics market has been categorized into comparative genomic hybridization (CGH), fluorescence in-situ hybridization (FISH), immunohistochemistry, karyotyping and others. The karyotyping technology market for molecular cytogenetics is further categorized into spectral and virtual. In 2017, spectral karyotyping held larger share, of 66.0%, in molecular cytogenetics market, owing to the usage of these technique for the detection of complex chromosomal aberration as well as for identification of new leukaemia subgroups.

During the forecast period, the molecular cytogenetics market is expected to witness fastest growth in personalized medicine application, at a CAGR of 10.1%. This growth is attributable to rise in demand for precision medicine coupled with high investments in research and development.

Based on end user, the molecular cytogenetics market has been classified into clinical and research laboratories, academic research institutes, hospitals and pathology laboratories and pharmaceutical and biotechnology companies. Among these, clinical and research laboratories held the largest share as an end-user category during the historical period in this market and accounted for a 33.4 % share in 2017.

Molecular cytogenetics market to witness fastest growth in Asia-Pacific (APAC)

During the forecast period, the molecular cytogenetics market is projected to witness fastest growth in APAC, at CAGR of 11.8%, mainly due to the large population in the region, untapped market and entry of global players in the industry to offer cytogenetic testing. Government initiatives such as mandatory testing, funding and training programs to the researchers are some other factors that are propelling the growth of the market in the region.

According to the World Bank, the healthcare expenditure of South Asia was 3.9% of its total GDP in 2000, which increased to 4.4% in 2014. The growing healthcare infrastructure in APAC is creating huge revenue generation opportunities for the pharmaceutical and biotechnology companies in the region.

Market players are focusing on developing technologically advanced molecular cytogenetics products

Globally, key players in the molecular cytogenetics industry are developing new instruments and tests for the molecular diagnosing, genetic screening and other tests. For instance, in July 2017, Quest Diagnostics announced the launch of a genetic screening service, QHerit. The service is for the detection of genetic risk associated to offspring through passing of heritable disorders. The QHerit Pan-Ethnic Expanded Carrier Screen is a panel of tests for the 22 heritable diseases cited under new screening guidelines issued in March 2017 by the American College of Gynecology (ACOG).

Some of the other key players operating in the molecular cytogenetics industry include Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann La-Roche AG, PerkinElmer Inc., Illumina Inc, Agilent Technologies Inc and NeoGenomics Inc.

Table of Content

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Offering
    • 1.3.2 Market Segmentation by Technology
    • 1.3.3 Market Segmentation by Application
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Geography
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
      • 1.3.7.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Offering
      • 4.1.1.1 Consumables
      • 4.1.1.2 Software and services
      • 4.1.1.3 Instruments
    • 4.1.2 By Technology
      • 4.1.2.1 Comparative genomic hybridization (CGH)
        • 4.1.2.1.1 Array-based CGH
        • 4.1.2.1.2 Standard CGH
      • 4.1.2.2 Fluorescence in situ hybridization (FISH)
      • 4.1.2.3 Immunohistochemistry (IHC)
      • 4.1.2.4 Karyotyping
        • 4.1.2.4.1 Spectral karyotyping (SKY)
        • 4.1.2.4.2 Virtual karyotyping
    • 4.1.3 By Application
      • 4.1.3.1 Cancer
      • 4.1.3.2 Genetic disorders
      • 4.1.3.3 Personalized medicine
      • 4.1.3.4 Others
    • 4.1.4 By End User
      • 4.1.4.1 Clinical and research laboratories
      • 4.1.4.2 Academic research institutes
      • 4.1.4.3 Hospitals and pathology laboratories
      • 4.1.4.4 Pharmaceutical and biotechnology companies
      • 4.1.4.5 Others
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
      • 4.2.1.1 Rising pharmacogenomics for disease management and drug development
      • 4.2.1.2 Rising prevalence of cancer
      • 4.2.1.3 Advancements in molecular cytogenetic techniques
      • 4.2.1.4 Growth in genetic-based prediction of chromosomal abnormalities
      • 4.2.1.5 Increasing molecular cytogenetics application in crop improvement
      • 4.2.1.6 Aging population and its vulnerability to chronic diseases
      • 4.2.1.7 Impact analysis of drivers on market forecast
    • 4.2.2 Restraints
      • 4.2.2.1 High cost of cytogenetics instruments
      • 4.2.2.2 Lack of skilled personnel
      • 4.2.2.3 Lack of regulatory framework and insufficient reimbursements
      • 4.2.2.4 Impact analysis of restraints on market forecast
  • 4.3 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast

  • 5.1 By Offering
  • 5.2 By Technology
    • 5.2.1 CGH Molecular Cytogenetics Market by Type
    • 5.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 5.3 By Application
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Offering
  • 6.2 By Technology
    • 6.2.1 CGH Molecular Cytogenetics Market by Type
    • 6.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 6.3 By Application
  • 6.4 By End User
  • 6.5 By Country
    • 6.5.1 U.S. Molecular Cytogenetics Market
      • 6.5.1.1 By offering
      • 6.5.1.2 By technology
        • 6.5.1.2.1 CGH molecular cytogenetics market by type
        • 6.5.1.2.2 Karyotyping molecular cytogenetics market by type
      • 6.5.1.3 By application
      • 6.5.1.4 By end user
    • 6.5.2 Canada Molecular Cytogenetics Market
      • 6.5.2.1 By offering
      • 6.5.2.2 By technology
        • 6.5.2.2.1 CGH molecular cytogenetics market by type
        • 6.5.2.2.2 Karyotyping molecular cytogenetics market by type
      • 6.5.2.3 By application
      • 6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Offering
  • 7.2 By Technology
    • 7.2.1 CGH Molecular Cytogenetics Market by Type
    • 7.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 7.3 By Application
  • 7.4 By End User
  • 7.5 By Country
    • 7.5.1 Germany Molecular Cytogenetics Market
      • 7.5.1.1 By offering
      • 7.5.1.2 By technology
        • 7.5.1.2.1 CGH molecular cytogenetics market by type
        • 7.5.1.2.2 Karyotyping molecular cytogenetics market by type
      • 7.5.1.3 By application
      • 7.5.1.4 By end user
    • 7.5.2 U.K. Molecular Cytogenetics Market
      • 7.5.2.1 By offering
      • 7.5.2.2 By technology
        • 7.5.2.2.1 CGH molecular cytogenetics market by type
        • 7.5.2.2.2 Karyotyping molecular cytogenetics market by type
      • 7.5.2.3 By application
      • 7.5.2.4 By end user

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Offering
  • 8.2 By Technology
    • 8.2.1 CGH Molecular Cytogenetics Market by Type
    • 8.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 8.3 By Application
  • 8.4 By End User
  • 8.5 By Country
    • 8.5.1 Japan Molecular Cytogenetics Market
      • 8.5.1.1 By offering
      • 8.5.1.2 By technology
        • 8.5.1.2.1 CGH molecular cytogenetics market by type
        • 8.5.1.2.2 Karyotyping molecular cytogenetics market by type
      • 8.5.1.3 By application
      • 8.5.1.4 By end user
    • 8.5.2 China Molecular Cytogenetics Market
      • 8.5.2.1 By offering
      • 8.5.2.2 By technology
        • 8.5.2.2.1 CGH molecular cytogenetics market by type
        • 8.5.2.2.2 Karyotyping molecular cytogenetics market by type
      • 8.5.2.3 By application
      • 8.5.2.4 By end user

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Offering
  • 9.2 By Technology
    • 9.2.1 CGH Molecular Cytogenetics Market by Type
    • 9.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 9.3 By Application
  • 9.4 By End User
  • 9.5 By Country
    • 9.5.1 Brazil Molecular Cytogenetics Market
      • 9.5.1.1 By offering
      • 9.5.1.2 By technology
        • 9.5.1.2.1 CGH molecular cytogenetics market by type
        • 9.5.1.2.2 Karyotyping molecular cytogenetics market by type
      • 9.5.1.3 By application
      • 9.5.1.4 By end user

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Offering
  • 10.2 By Technology
    • 10.2.1 CGH Molecular Cytogenetics Market by Type
    • 10.2.2 Karyotyping Molecular Cytogenetics Market by Type
  • 10.3 By Application
  • 10.4 By End User
  • 10.5 By Country
    • 10.5.1 South Africa Molecular Cytogenetics Market
      • 10.5.1.1 By offering
      • 10.5.1.2 By technology
        • 10.5.1.2.1 CGH molecular cytogenetics market by type
        • 10.5.1.2.2 Karyotyping molecular cytogenetics market by type
      • 10.5.1.3 By application
      • 10.5.1.4 By end user

Chapter 11. Global Strategic Developments

  • 11.1 Mergers and Acquisitions
  • 11.2 Product Launches and Approvals
  • 11.3 Partnerships
  • 11.4 Other Developments

Chapter 12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Danaher Corporation
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Bio-Rad Laboratories Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 F. Hoffmann La-Roche AG
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Agilent Technologies Inc.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 PerkinElmer Inc.
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Illumina Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Quest Diagnostics Inc.
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 NeoGenomics Inc.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports
Back to Top